Ra Capital Management, L.P. Cyteir Therapeutics, Inc. Transaction History

Ra Capital Management, L.P.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$1.62 - $4.4 $5.43 Million - $14.7 Million	-3,350,506 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$14.57 - $21.86 $1.51 Million - $2.26 Million	103,389 Added 3.18%	3,350,506 $58.8 Million
Q2 2021 Aug 16, 2021	BUY	$16.8 - $21.4 $54.6 Million - $69.5 Million	3,247,117 New	3,247,117 $69.5 Million

6.18M

Ticker CYT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 35,413,400
Market Cap $107M
Description
Cyteir Therapeutics, Inc., a clinical-stage biotechnology company, develops and commercializes the next-generation of precision oncology medicines. Its lead product CYT-0851, a novel, oral, once-daily, small molecule drug candidate that is in Phase I/II clinical trial for monotherapy in solid tumors and hematologic malignancies, as well as for c...

Get notified when there are updates to the investment portfolio of Ra Capital Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Ra Capital Management, L.P. with notifications on news.